Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
J Clin Med ; 11(9)2022 Apr 27.
Article in English | MEDLINE | ID: mdl-35566585

ABSTRACT

In recent years, antioxidant supplements have become popular to counteract the effects of oxidative stress in fibromyalgia and one of its most distressing symptoms, pain. The aim of this systematic review was to summarize the effects of antioxidant supplementation on pain levels perceived by patients diagnosed with fibromyalgia. The words used respected the medical search terms related to our objective including antioxidants, fibromyalgia, pain, and supplementation. Seventeen relevant articles were identified within Medline (PubMed), Scopus, Web of Science (WOS), the Cochrane Database of Systematic Review, and the Cochrane Central Register of Controlled Trials. This review found that antioxidant supplementation is efficient in reducing pain in nine of the studies reviewed. Studies with a duration of supplementation of at least 6 weeks showed a benefit on pain perception in 80% of the patients included in these studies. The benefits shown by vitamins and coenzyme Q10 are remarkable. Further research is needed to identify the effects of other types of antioxidants, such as extra virgin olive oil and turmeric. More homogeneous interventions in terms of antioxidant doses administered and duration would allow the effects on pain to be addressed more comprehensively.

2.
Nutrients ; 14(2)2022 Jan 08.
Article in English | MEDLINE | ID: mdl-35057442

ABSTRACT

Candidate gene studies have analyzed the effect of specific vitamin D pathway genes on vitamin D availability; however, it is not clear whether genetic variants also affect overall bone metabolism. This study evaluated the association between genetic polymorphisms in GC, CYP2R1 and CYP24A1 and serum levels of total 25(OH)D, iPTH and other mineral metabolism biomarkers (albumin, total calcium and phosphorus) in a sample of 273 older Spanish adults. We observed a significant difference between CYP2R1 rs10741657 codominant model and total 25(OH)D levels after adjusting them by gender (p = 0.024). In addition, the two SNPs in the GC gene (rs4588 and rs2282679) were identified significantly associated with iPTH and creatinine serum levels. In the case of phosphorus, we observed an association with GC SNPs in dominant model. We found a relationship between haplotype 2 and 25(OH)D levels, haplotype 4 and iPTH serum levels and haplotype 7 and phosphorus levels. In conclusion, genetic variants in CYP2R1 and GC could be predictive of 25(OH)D and iPTH serum levels, respectively, in older Caucasian adults. The current study confirmed the role of iPTH as one of the most sensitive biomarkers of vitamin D activity in vivo.


Subject(s)
Bone Density/genetics , Cholestanetriol 26-Monooxygenase/genetics , Cytochrome P450 Family 2/genetics , Haplotypes , Parathyroid Hormone/blood , Vitamin D-Binding Protein/genetics , Vitamin D3 24-Hydroxylase/genetics , Vitamin D/analogs & derivatives , Aged , Aged, 80 and over , Calcium/blood , Creatinine/blood , Cross-Sectional Studies , Female , Humans , Male , Phosphorus/blood , Polymorphism, Single Nucleotide , Serum Albumin/analysis , Sex Factors , Vitamin D/blood , White People
3.
Nutrients ; 11(11)2019 Nov 12.
Article in English | MEDLINE | ID: mdl-31726780

ABSTRACT

As the relationship between vitamin D and various diseases or health conditions has become known, interest in the contribution of vitamin D to overall health-related quality of life (QoL) has increased. We examined the relationship between vitamin D status and QoL in 273 participants aged 65 years and older. Serum levels of total calcium, phosphorus, intact parathyroid hormone, albumin, and 25-hydroxyvitaminD3 were analyzed. We also recruited data for QoL, physical activity, nutritional impairment, and muscular strength. Ninety percent of the subjects were classified as vitamin D deficient or insufficient. Participants with higher serum 25(OH)D3, calcium, phosphorous, and Alb levels were significantly less likely to self-report depression or anxiety after adjustment (p = 0.009, p = 0.005, p = 0.003, and p = 0.005, respectively). Additionally, we found an association between lower levels of albumin and self-reported problems with mobility or usual activities (p = 0.01). We also found associations between better muscle strength and higher levels of vitamin D, calcium, phosphorous, and albumin (p = 0.006, p = 0.003, p = 0.004 and p = 0.002, respectively). Overall, our data provide evidence that serum vitamin D and Alb levels are negatively related to self-reported anxiety or depression, usual activities, mobility, and three dimensions of QoL in older adults. Furthermore, vitamin D levels are positively related to hand grip strength in adults over 65 years old.


Subject(s)
Bone Density , Bone and Bones/metabolism , Healthy Aging/metabolism , Muscle Strength , Muscle, Skeletal/physiology , Quality of Life , Affect , Age Factors , Aged , Aged, 80 and over , Biomarkers/blood , Calcifediol/blood , Calcium/blood , Cross-Sectional Studies , Female , Health Status , Healthy Aging/psychology , Humans , Male , Mental Health , Parathyroid Hormone/blood , Phosphorus/blood , Serum Albumin, Human/analysis , Spain
4.
PLoS One ; 5(6): e11210, 2010 Jun 18.
Article in English | MEDLINE | ID: mdl-20585445

ABSTRACT

The identification of CYP2C9 and VKORC1 genes has strongly stimulated the research on pharmacogenetics of coumarins in the last decade. We assessed the combined influence of CYP2C9 *2 and *3, and VKORC1 c.-1639G>A, 497C>G, and 1173C>T variants, on acenocoumarol dosage using a novel algorithm approach, in 193 outpatients who had achieved stable anticoagulation. We constructed an "acenocoumarol-dose genotype score" (AGS, maximum score = 100) based on the number of alleles associated with higher acenocoumarol dosage carried by each subject for each polymorphism. The mean AGS was higher in the high-dose (> 28 mg/week) compared with the low-dose (< 7 mg/week) group (mean(SEM) of 84.1+/-3.4 vs. 62.2+/-4.8, P = 0.008). An AGS > 70 was associated with an increased odds ratio (OR) of requiring high acenocoumarol dosage (OR: 3.347; 95%CI: 1.112-10.075; P = 0.032). In summary, although more research is necessary in other patient cohorts, and this algorithm should be replicated in an independent sample, our data suggest that the AGS algorithm could be used to help discriminating patients requiring high acenocoumarol doses to achieve stable anti-coagulation.


Subject(s)
Acenocoumarol/pharmacology , Algorithms , Alleles , Anticoagulants/pharmacology , Aryl Hydrocarbon Hydroxylases/genetics , Mixed Function Oxygenases/genetics , Acenocoumarol/pharmacokinetics , Anticoagulants/pharmacokinetics , Area Under Curve , Cytochrome P-450 CYP2C9 , Dose-Response Relationship, Drug , Humans , Pharmacogenetics , Polymorphism, Genetic , Vitamin K Epoxide Reductases
SELECTION OF CITATIONS
SEARCH DETAIL